The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine has created uncertainty across the vaccine industry, potentially affecting ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine -- the nation's only traditional ...

American experts who analysed the vaccine trial data said what was causing the reaction in the small trial of just over 100 ...

(Corrects to fix typo in paragraph 4) (Reuters) -Life science real estate investment trust Alexandria Real Estate Equities reduced its full-year forecast for adjusted funds from operations (FFO) on ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced ...

Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the ...

In addition, HHS Secretary Robert F. Kennedy Jr addressed the delay in Novavax's approval in a CBS interview earlier this ...

US pharmaceutical giant Moderna is under serious scrutiny in the United Kingdom after allegations emerged that the company ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...